Cancer invasion and tissue remodeling - cooperation of protease systems and cell types

被引:265
作者
Dano, K
Romer, J
Nielsen, BS
Bjorn, S
Pyke, C
Rygaard, J
Lund, LR
机构
[1] Rigshosp, Finsen Lab, DK-2100 Copenhagen O, Denmark
[2] Novo Nordisk AS, Hlth Care Discovery, Histol, DK-2880 Bagsvaerd, Denmark
[3] Bartholin Inst, Copenhagen, Denmark
关键词
cancer invasion; tissue remodeling; proteases; stromal cells; plasminogen; MMPs;
D O I
10.1111/j.1699-0463.1999.tb01534.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Proteolytic degradation of the extracellular matrix plays a crucial role in both cancer invasion and non-neoplastic tissue remodeling processes. In human cancers the components of matrix degrading protease systems (uPA, uPAR, PAI-1 and MMPs) can be expressed by either the non-neoplastic stromal cells, the cancer cells or both. Studies of the prognostic impact of these components in human cancer and the effect of targeted gene inactivation on cancer metastasis in mice support the assumption that proteases promote cancer progression, independent of whether they are expressed by cancer cells or stromal cells. The pattern of expression of components of protease systems is usually very similar in different cases of the same type of cancer, while it varies between different types of cancer. There are intriguing similarities between the cellular expression pattern of components of protease systems seen in cancer invasion and in certain types of non-neoplastic tissue remodeling. We propose that cancer invasion can be viewed as tissue remodeling gone out of control. The stromal cell involvement in cancer invasion represents a new paradigm with important implications for cancer pathophysiology and cancer therapy.
引用
收藏
页码:120 / 127
页数:8
相关论文
共 106 条
  • [31] GRONDAHLHANSEN J, 1993, CANCER RES, V53, P2513
  • [32] Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation
    Henriet, P
    Blavier, L
    DeClerck, YA
    [J]. APMIS, 1999, 107 (01) : 111 - 119
  • [33] Heppner KJ, 1996, AM J PATHOL, V149, P273
  • [34] Stromal cell expression of components of matrix-degrading protease systems in human cancer
    Hewitt, R
    Dano, K
    [J]. ENZYME & PROTEIN, 1996, 49 (1-3) : 163 - 173
  • [35] HYDAYAT AA, 1987, OPHTHALMOLOGY, V94, P949
  • [36] Itoh T, 1998, CANCER RES, V58, P1048
  • [37] Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation
    Johnsen, M
    Lund, LR
    Romer, J
    Almholt, K
    Dano, K
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (05) : 667 - 671
  • [38] PLASMINOGEN-ACTIVATOR INHIBITOR-TYPE-1 IN LEWIS LUNG-CARCINOMA
    KRISTENSEN, P
    PYKE, C
    LUND, LR
    ANDREASEN, PA
    DANO, K
    [J]. HISTOCHEMISTRY, 1990, 93 (06) : 559 - 566
  • [39] 2 ALTERNATIVELY SPLICED MOUSE UROKINASE RECEPTOR MESSENGER-RNAS WITH DIFFERENT HISTOLOGICAL LOCALIZATION IN THE GASTROINTESTINAL-TRACT
    KRISTENSEN, P
    ERIKSEN, J
    BLASI, F
    DANO, K
    [J]. JOURNAL OF CELL BIOLOGY, 1991, 115 (06) : 1763 - 1771
  • [40] DISTRIBUTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IMMUNOREACTIVITY IN THE MOUSE
    LARSSON, LI
    SKRIVER, L
    NIELSEN, LS
    GRONDAHLHANSEN, J
    KRISTENSEN, P
    DANO, K
    [J]. JOURNAL OF CELL BIOLOGY, 1984, 98 (03) : 894 - 903